Sage Therapeutics Announces Topline Results from the Phase 2 DIMENSION Study of Dalzanemdor in the Treatment of Cognitive Impairment Associated with Huntingtons Disease
| ETAGX Fund | USD 50.19 0.03 0.06% |
Slightly above 61% of Eventide Gilead's investor base is looking to short. The analysis of overall sentiment of trading Eventide Gilead mutual fund suggests that many investors are alarmed at this time. Eventide Gilead's investing sentiment can be driven by a variety of factors including economic data, Eventide Gilead's earnings reports, geopolitical events, and overall market trends.
Eventide |
Sage Therapeutics, Inc. today announced topline results from the Phase 2 DIMENSION Study of dalzanemdor in participants with
Read at businesswire.com
 |
Eventide Gilead Fundamental Analysis
We analyze Eventide Gilead's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eventide Gilead using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eventide Gilead based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Ten Year Return
Ten Year Return Comparative Analysis
Eventide Gilead is currently under evaluation in ten year return among similar funds. Ten Year Return shows the total annualized return generated from holding a fund for the last 10 years and represents fund's capital appreciation, including dividends losses and capital gains distributions. This return indicator is considered by many investors to be the ultimate measures of fund performance and can reflect the overall performance of the market or market segment it invests in.
Eventide Gilead Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Eventide Gilead mutual fund to make a market-neutral strategy. Peer analysis of Eventide Gilead could also be used in its relative valuation, which is a method of valuing Eventide Gilead by comparing valuation metrics with similar companies.
Peers
Eventide Gilead Related Equities
| ETIEX | Eventide Exponential | 2.24 | ||||
| 70082LAB3 | 70082LAB3 | 1.58 | ||||
| VIASP | Via Renewables | 0.94 | ||||
| MSTSX | Morningstar Unconstrained | 0.37 | ||||
| ETIDX | Eventide Global | 0.11 | ||||
| ETGLX | Eventide Gilead | 0.08 | ||||
| LBHIX | Thrivent High | 0.24 | ||||
| RRTLX | T Rowe | 2.90 |
Other Information on Investing in Eventide Mutual Fund
Eventide Gilead financial ratios help investors to determine whether Eventide Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eventide with respect to the benefits of owning Eventide Gilead security.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |